Ecstasy Agonistes

A retracted study on a controversial substance raises questions about the reliability of government-sponsored research on drugs

Colloquy Live: Read the transcript of a live, online discussion with Rick Doblin, president of the Multidisciplinary Association for Psychedelic Studies, about research on the drug Ecstasy and whether its dangers have been overstated for political reasons.

Timeline: Key Moments in Ecstasy ResearchBy THOMAS BARTLETT

Until recently, Ecstasy had been

Digital or Print Subscription

Already have an account? Log In Now.